How SSRIs Work and What to Expect When Starting Them

The hardest part of starting an SSRI is that the side effects show up before the benefits do. Week one can bring nausea and restless sleep. Week four is where the mood usually starts to move. That gap is where most people decide the medication is not for them, and a large share of them were about two weeks from finding out it was.

So the most useful thing we can do at the visit where we prescribe one is describe the shape of the next six weeks honestly. Not a promise, a shape. This post is that conversation written down.

What an SSRI actually does

SSRI stands for selective serotonin reuptake inhibitor. After a nerve cell releases serotonin into the gap between neurons, it normally reabsorbs most of it. An SSRI slows that reabsorption, so serotonin stays in the gap longer.

That is the mechanism. What it is not is a fix for a "serotonin deficiency," and you should be skeptical of anyone who describes it that way. The chemical imbalance framing was always a simplification, and it does not survive contact with the evidence. The honest version is that these medications reliably reduce symptoms of depression and several anxiety disorders in controlled trials, and the downstream changes in how neurons adapt over weeks probably matter more than the immediate serotonin effect.

That timing mismatch is not a footnote. The serotonin change happens within hours. The clinical benefit takes weeks. Whatever is doing the therapeutic work is slower than the mechanism the drug is named after, and that is precisely why patience in the first month is not just encouragement, it is pharmacology.

Do they actually work?

Yes, with honest caveats about size.

The largest analysis of this question compared 21 antidepressants across hundreds of trials and found all of them more effective than placebo for acute treatment of major depression in adults, with modest differences between individual drugs in both efficacy and how well people tolerated them (https://pubmed.ncbi.nlm.nih.gov/29477251/). The differences between agents were real but small enough that "which one" matters less than "an adequate trial of one."

The caveats worth stating: average benefit across a population conceals wide variation between individuals, and these medications work considerably better for moderate to severe depression than for mild symptoms. For milder presentations, therapy alone is often the better first move, and cognitive behavioral therapy has strong evidence in anxiety disorders specifically (https://pubmed.ncbi.nlm.nih.gov/29451967/).

The first six weeks, week by week

Week 1. This is the roughest stretch and it is almost entirely side effects. Nausea, headache, looser stools, disturbed sleep, and sometimes an increase in anxiety or jitteriness in the first days. That early anxiety bump is real, it is well recognized, and it is temporary. Taking the dose with food helps the nausea. Most of this settles within seven to ten days.

Week 2. Physical side effects usually ease. Sleep and appetite are often the first things to shift, sometimes before you would describe your mood as better. People frequently report this in retrospect rather than noticing at the time.

Weeks 3 to 4. The mood change typically begins here. It is rarely dramatic. The more common description is that things feel slightly less heavy, or that something that would have derailed the whole day only cost an hour.

Weeks 4 to 6. This is where we judge whether the medication is working. If there has been partial improvement, continuing at the same dose or adjusting is reasonable. If there has been nothing at all, that is a real signal, and it is the point to change something rather than wait longer.

A note on the family that watches you take it: other people often notice improvement before you do. That is common enough that we ask.

The dose question

There is a widespread assumption that if a medication is not working, the answer is more of it. For SSRIs, the evidence pushes back on this.

A dose-response meta-analysis of SSRIs, venlafaxine, and mirtazapine found that benefit largely plateaus in the lower to middle portion of the licensed dose range, while side effects and dropouts continue to rise as dose increases (https://pubmed.ncbi.nlm.nih.gov/31178367/). In plain terms: past a certain point you are buying side effects rather than improvement.

That does not mean dose never gets increased. It means an increase should be a considered decision with a reason, not the automatic next step. Often the better move is switching to a different agent, adding therapy, or looking hard at what else is going on: sleep, thyroid, alcohol, an untreated anxiety disorder underneath the depression, or a life circumstance no medication is going to solve.

The side effects that fade, and the ones that do not

Usually fade within one to two weeks: nausea, headache, loose stools, initial jitteriness, early sleep disruption.

Often persist and need active management:

Sexual side effects. Reduced desire, delayed orgasm, and erectile difficulty are common with this class and, unlike the gastrointestinal effects, they frequently do not resolve with time (https://pubmed.ncbi.nlm.nih.gov/25148932/, https://pubmed.ncbi.nlm.nih.gov/12971810/). This is the effect people are least likely to raise unprompted and most likely to quietly stop the medication over. We ask directly for that reason. There are documented management strategies including dose adjustment, timing changes, switching to an agent with a lower rate, or adding another medication (https://pubmed.ncbi.nlm.nih.gov/39100123/). None of them work if we do not know.

Emotional blunting. A minority describe feeling less of everything rather than less of the bad. It is worth reporting because it usually responds to a dose reduction or a switch.

Weight change. Variable by agent and by person, and more likely over months than weeks.

Sweating and vivid dreams. Common, benign, sometimes persistent.

Stopping, and why it needs a plan

SSRIs are not addictive. They do not cause craving or escalating use. But stopping abruptly commonly produces discontinuation symptoms: dizziness, electric-shock sensations, flu-like feelings, irritability, and sleep disruption.

How often this happens and how severe it is has been actively debated, and two recent meta-analyses have tried to pin the numbers down more carefully (https://pubmed.ncbi.nlm.nih.gov/38851198/, https://pubmed.ncbi.nlm.nih.gov/40632531/). What is not in dispute is the practical implication: taper rather than stop, taper more slowly for agents with a short half-life, and do not time it for the same week as a major life stressor.

The other stopping question is when. Guidance generally supports continuing well past the point of feeling better, because stopping at the moment of recovery carries a higher relapse risk than continuing for a period of stability first. How long depends on whether this is a first episode or a recurrence.

When an SSRI is not the right first step

We do not reach for a prescription automatically, and a few situations specifically call for something else first.

If symptoms are mild, therapy alone is often the better opening move. If there is any history of mania or hypomania, an SSRI alone can be the wrong and occasionally harmful choice, so we screen for it before prescribing. If the dominant problem is untreated ADHD, the mood symptoms often improve when the ADHD is addressed, and our post on adult ADHD evaluation and treatment covers that overlap. If sleep apnea, thyroid disease, anemia, or heavy alcohol use is in the picture, treating those changes the whole calculation.

And if two adequate SSRI trials have genuinely failed, that is a recognized clinical category with its own options rather than a dead end. Our post on ketamine versus esketamine covers one of those paths.

What a good first six weeks looks like with us

You should not be handed a prescription and a three-month follow-up. We check in early, because week one is when the side effects peak and when people quit.

We set the expectation before you start: rough first week, physical effects settling by week two, mood beginning to move around weeks three and four, formal reassessment at six. We ask about sexual side effects directly rather than waiting for you to raise them. We do not increase the dose reflexively when the first four weeks are underwhelming. And we plan the eventual taper at the start, not as an afterthought.

If you are considering starting an antidepressant, or you are on one and it does not feel like it is working, book a visit through our mental health services at nomibeach.health or call (786) 744-5152. Bring what you have already tried, including what you stopped and why. That history usually points at the answer faster than starting from scratch.